EcoDrugPlus

Integrin Subunit Beta 1

Ensembl ID : ENSPNAG00000008014
Gene Symbol: ITGB1
3 Cross references
215 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPNAG00000016054
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSPNAG00000010320
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSPNAG00000014568
Gene Symbol: ITGB7
3 Cross references
150 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSPNAG00000002043
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSPNAG00000017853
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSPNAG00000025794
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSPNAG00000001970
Gene Symbol: IDH2
3 Cross references
207 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSPNAG00000000163
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSPNAG00000009632
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSPNAG00000006552
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPNAG00000001000
Gene Symbol: KIF5B
3 Cross references
270 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).